Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Wyeth presents various series of PAI-1 inhibitors

Feb. 11, 2003

Design and synthesis of potent and selective direct thrombin inhibitors

Feb. 10, 2003

ZymoGenetics initiates rFXIII phase I trials, signs exclusive licensing agreement

Feb. 7, 2003

MIT details the rational design of LMWHs with improved properties

Feb. 6, 2003

Baxter proposes Advate as brand name for rAHF-PFM

Feb. 6, 2003

Research term extended in 3DP thrombin collaboration

Feb. 6, 2003

Boehringer Ingelheim presents novel thrombin inhibitors

Feb. 6, 2003

Novel factor Xa inhibitors developed at BMS

Feb. 5, 2003

First treatment for acute ischemic stroke cleared for use in Europe

Jan. 29, 2003

Novel antagonists of platelet ADP (P2YAC) receptors discovered at Schering AG

Jan. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...